AGP Picks
View all

Healthcare News Papua New Guinea
Provided by AGP

Healthcare News Papua New Guinea: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare News Papua New Guinea.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 27, 2026

Cato Healthcare Supply Appoints Ryan F. Zackon as President and Chief Executive Officer
40 minutes ago

Cato Healthcare Supply Appoints Ryan F. Zackon as President and Chief Executive Officer

Indeterminate GlobeNewswire
Flourish Health Raises $46M to Scale Intensive Mental Health Care for Youth in Crisis
an hour ago

Flourish Health Raises $46M to Scale Intensive Mental Health Care for Youth in Crisis

Indeterminate GlobeNewswire
Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)
an hour ago

Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM)

Indeterminate GlobeNewswire
Cristcot Presents Poster and Select Oral Presentation for Implementing Endocrine Principles to Assess Safety and Compliance within a Clinical Trial at ENDO 2026
an hour ago

Cristcot Presents Poster and Select Oral Presentation for Implementing Endocrine Principles to Assess Safety and Compliance within a Clinical Trial at ENDO 2026

Indeterminate GlobeNewswire
Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update
an hour ago

Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update

Indeterminate GlobeNewswire
Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement
an hour ago

Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement

Indeterminate GlobeNewswire
NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million
an hour ago

NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million

Indeterminate GlobeNewswire
SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity
an hour ago

SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity

Indeterminate GlobeNewswire
Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome
an hour ago

Medicus Pharma Receives FDA “Study May Proceed” Letter for NDA-Enabling Registrational SkinJect® Study in Patients with Gorlin Syndrome

Indeterminate GlobeNewswire
Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
an hour ago

Veru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

Indeterminate GlobeNewswire
Pluristyx Partners With Leading Regenerative Medicine and Aerospace Pioneers to Standardize Clinical-Grade Hepatocyte Manufacturing for Space and Earth Applications
an hour ago

Pluristyx Partners With Leading Regenerative Medicine and Aerospace Pioneers to Standardize Clinical-Grade Hepatocyte Manufacturing for Space and Earth Applications

Indeterminate GlobeNewswire
CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors
an hour ago

CytomX Therapeutics Announces Appointment of Charles Fuchs, M.D., M.P.H., to the Board of Directors

Indeterminate GlobeNewswire
Sofwave to Participate in 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
an hour ago

Sofwave to Participate in 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Indeterminate GlobeNewswire
Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research
an hour ago

Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research

Indeterminate GlobeNewswire
Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors
an hour ago

Inspire Medical Systems, Inc. Announces Appointment of Seasoned Medical Device Executive Michael H. Carrel to its Board of Directors

Indeterminate GlobeNewswire
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
an hour ago

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing

Indeterminate GlobeNewswire
Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel
an hour ago

Kyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel

Indeterminate GlobeNewswire
Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
an hour ago

Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process

Indeterminate GlobeNewswire
FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.
an hour ago

FDA Approves Freenome’s SimpleScreen™ CRC Blood-Based Screening Test; Abbott to Commercialize in the U.S.

Indeterminate GlobeNewswire
Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference
an hour ago

Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare News Papua New Guinea

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.